Skip to content
10-K

Annual Report

IN8BIO, INC. INAB

0001193125-26-104181

← back to feed
Filed
Mar 12, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 4.37M sh
Shares Diluted restated FY 2025 · Dec 31, 2024 1.78M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$12.71M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$24.15M
Cash And Equivalents FY 2025 · Dec 31, 2025 $27.31M
Cash And Equivalents FY 2025 · Dec 31, 2024 $11.39M
Cash And Equivalents FY 2025 · Dec 31, 2023 $21.54M
Stockholders Equity FY 2025 · Dec 31, 2025 $27.56M
Stockholders Equity FY 2025 · Dec 31, 2024 $14.48M
Stockholders Equity FY 2025 · Dec 31, 2023 $24.94M
Current Liabilities FY 2025 · Dec 31, 2025 $3.16M
Current Liabilities FY 2025 · Dec 31, 2024 $3.08M
Total Liabilities FY 2025 · Dec 31, 2025 $4.72M
Total Liabilities FY 2025 · Dec 31, 2024 $6.47M
Current Assets FY 2025 · Dec 31, 2025 $27.88M
Current Assets FY 2025 · Dec 31, 2024 $12.58M
Total Assets FY 2025 · Dec 31, 2025 $32.28M
Total Assets FY 2025 · Dec 31, 2024 $20.94M
Eps Diluted FY 2025 · Dec 31, 2025 −$4.44
Eps Diluted restated FY 2025 · Dec 31, 2024 −$17.05
Eps Basic FY 2025 · Dec 31, 2025 −$4.44
Eps Basic restated FY 2025 · Dec 31, 2024 −$17.05
Sga Expense FY 2025 · Dec 31, 2025 $9.65M
Sga Expense FY 2025 · Dec 31, 2024 $12.64M
Rd Expense FY 2025 · Dec 31, 2025 $10.21M
Rd Expense FY 2025 · Dec 31, 2024 $16.96M
Net Income FY 2025 · Dec 31, 2025 −$19.44M
Net Income FY 2025 · Dec 31, 2024 −$30.44M
Operating Income FY 2025 · Dec 31, 2025 −$19.44M
Operating Income FY 2025 · Dec 31, 2024 −$30.44M